Keating, Gillian M.

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

Garnock-Jones, K. P., & Keating, G. M. (2009) · Pediatric Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 392

Memantine: A Review of Its Use in Alzheimer’s Disease

Robinson, D. M., & Keating, G. M. (2006) · Drugs

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 277

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

Keating, G. M., & Croom, K. F. (2007) · Drugs

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 169

Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients

Syed, Y. Y., & Keating, G. M. (2013) · CNS Drugs

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 72

Lisdexamfetamine

Blick, S. K. A., & Keating, G. M. (2007) · Pediatric Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 50

Cevimeline

Weber, J., & Keating, G. M. (2008) · Drugs

Salivary Gland Disorders and FunctionsOcular Surface and Contact Lens

Cited by 33

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

Garnock-Jones, K. P., & Keating, G. M. (2010) · CNS Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 32

Evolocumab: A Review in Hyperlipidemia

Keating, G. M. (2016) · American Journal of Cardiovascular Drugs

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 19